NCT06217016 2025-08-28
Effect of ICCAUT Strategy on Postoperative Urinary Retention After Radical Rectal Cancer Surgery (ICCAUT-2)
The First Hospital of Jilin University
Phase NA Withdrawn
Clinical Trials
54 trialsNCT06895577 2025-05-21
Neoadjuvant Chemoradiotherapy Plus Sintilimab for MSS, Locally Advanced Rectal Cancer-
Sun Yat-sen University
Phase 2 Withdrawn
NCT05356897 2024-09-19
Tucatinib Combined with Trastuzumab and TAS-102 for the Treatment of HER2 Positive Metastatic Colorectal Cancer in Molecularly Selected Patients, 3T Study
Academic and Community Cancer Research United
Phase 2 Withdrawn
NCT05471401 2024-06-13
GI Organ Tracking Via Balloon Applicators
Washington University School of Medicine
Phase NA Withdrawn
NCT05900648 2024-04-29
Regorafenib and XmAb20717 in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy (RX-CROME)
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT05356585 2024-04-12
Circulating Tumor DNA to Monitor the Efficacy of Total Neoadjuvant Therapy for Rectal Cancer
Case Comprehensive Cancer Center
Withdrawn
NCT04379830 2024-01-05
Preoperative Very Low Energy Diet for Obese Rectal Cancer Patients
McMaster University
Phase NA Withdrawn
NCT01023984 2023-09-08
TEMENDO
European Association for Endoscopic Surgery
Phase 4 Withdrawn
NCT02682485 2023-04-26
SES-DTA
University of Chicago
Phase 2 Withdrawn
NCT04811833 2023-04-05
GASTROMO
Aesculap AG
Withdrawn
NCT00936832 2022-08-30
Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery
Federation Francophone de Cancerologie Digestive
Phase 2 Withdrawn
NCT04670588 2022-07-18
Response Assessment by Circulating Tumor DNA in Patients With Locally Advanced Rectal Cancer
Medical College of Wisconsin
Withdrawn
NCT04418895 2021-11-10
Neoadjuvant Therapy for Localized Rectal Adenocarcinoma
UNC Lineberger Comprehensive Cancer Center
Phase 2 Withdrawn
NCT04620473 2021-09-28
Anlotinib Hydrochloride Combined With Capeox in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Shanghai Minimally Invasive Surgery Center
Phase 2 Withdrawn
NCT03633539 2021-09-10
mSILSC
Ruijin Hospital
Phase NA Withdrawn
NCT01915472 2021-08-19
A Phase II Study of IMMU 130 in Patients With Metastatic Colorectal Cancer
Gilead Sciences
Phase 2 Withdrawn
NCT04561414 2021-04-12
IRIS
Stryker Orthopaedics
Phase NA Withdrawn
NCT03257332 2020-12-04
EDFI-Cohort
Slagelse Hospital
Withdrawn
NCT01097239 2020-11-20
Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer
Imperial College London
Phase 1/2 Withdrawn
NCT01302613 2020-08-20
Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma
University of Texas Southwestern Medical Center
Phase 1/2 Withdrawn
NCT03049124 2020-03-10
Exercise for Adults Diagnosed With Rectal Cancer
University of Ottawa
Phase NA Withdrawn
NCT03413930 2020-02-17
Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer
Ruijin Hospital
Phase NA Withdrawn
NCT00835055 2019-04-05
Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer
St. Claraspital AG
Withdrawn
NCT00651677 2019-01-14
Hand Assisted Versus "Pure" Laparoscopic Assisted Proctectomy for Rectal Cancer
Weill Medical College of Cornell University
Phase NA Withdrawn
NCT00005030 2018-11-14
SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the Liver
M.D. Anderson Cancer Center
Phase 1 Withdrawn
NCT01919541 2018-03-22
Mechanistic Prehabilitation
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase NA Withdrawn
NCT03007771 2017-10-06
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
Washington University School of Medicine
Phase 1 Withdrawn
NCT00002664 2017-07-13
Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With Metastatic Colorectal Cancer
George Washington University
Phase 2 Withdrawn
NCT01095523 2017-07-02
Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases
National Institutes of Health Clinical Center (CC)
Phase 2 Withdrawn
NCT00408772 2017-06-09
Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer
University of California, Davis
Phase 2 Withdrawn
NCT01270438 2017-04-04
Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT01032590 2017-03-06
Internet-Based Weight-Loss Program for Colorectal Cancer Survivors
Rutgers, The State University of New Jersey
Phase NA Withdrawn
NCT02046538 2017-01-25
Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal Cancer
Weill Medical College of Cornell University
Phase 2 Withdrawn
NCT02586610 2017-01-20
Trial of Chemoradiation and Pembrolizumab in Patients With Rectal Cancer
Hoosier Cancer Research Network
Phase 2 Withdrawn
NCT02287727 2016-10-12
Regorafenib in Reducing Recurrence in Patients With Non-metastatic Rectal Cancer Who Have Completed Curative-Intent Treatment
Roswell Park Cancer Institute
Phase 2 Withdrawn
NCT02112240 2016-07-15
Feasibility Study to Develop Sentinel Lymph Node Mapping in Rectal Cancer Patients
University of Virginia
Phase NA Withdrawn
NCT00571740 2016-07-06
Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Withdrawn
NCT02575508 2016-05-20
Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer
Roswell Park Cancer Institute
Phase 1/2 Withdrawn
NCT02235324 2015-05-06
Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer
University of Southern California
Phase 2 Withdrawn
NCT00575640 2015-03-04
Hydralazine as a Demethylating Agent in Rectal Cancer
University of Arkansas
Phase 1/2 Withdrawn
NCT01659424 2014-12-18
HDRBT
Beth Israel Medical Center
Phase 2 Withdrawn
NCT01941173 2014-07-21
Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy
City of Hope Medical Center
Phase NA Withdrawn
NCT00003786 2014-03-07
Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer
University of Chicago
Phase 2 Withdrawn
NCT01605344 2014-02-27
Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI
UNC Lineberger Comprehensive Cancer Center
Phase 1 Withdrawn
NCT01403103 2014-01-17
Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT00026468 2013-07-24
Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis
University of Utah
Phase 2/3 Withdrawn
NCT00960427 2013-04-16
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
Barbara Ann Karmanos Cancer Institute
Phase 1 Withdrawn
NCT00118105 2013-01-03
S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer
SWOG Cancer Research Network
Phase 2 Withdrawn
NCT00025532 2012-09-14
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer
University of California, San Francisco
Phase 1 Withdrawn
NCT00070434 2012-06-07
S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum
SWOG Cancer Research Network
Phase 2 Withdrawn